NEW YORK (GenomeWeb) – Natera and Belgian cancer reference center Institut Jules Bordet plan to collaborate on a breast cancer research project using Natera's circulating tumor DNA assay, Signatera.
Natera will analyze around 300 plasma samples prospectively collected from 80 patients diagnosed with non-metastatic breast cancer who were all treated with chemotherapy followed by surgery.